The Receptor-Binding Site of the Measles Virus Hemagglutinin Protein Itself Constitutes a Conserved Neutralizing Epitope

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 87; no. 6; pp. 3583 - 3586
Main Authors Tahara, Maino, Ohno, Shinji, Sakai, Kouji, Ito, Yuri, Fukuhara, Hideo, Komase, Katsuhiro, Brindley, Melinda A., Rota, Paul A., Plemper, Richard K., Maenaka, Katsumi, Takeda, Makoto
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.03.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature.
Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature.Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Author Richard K. Plemper
Kouji Sakai
Makoto Takeda
Hideo Fukuhara
Melinda A. Brindley
Yuri Ito
Maino Tahara
Shinji Ohno
Paul A. Rota
Katsuhiro Komase
Katsumi Maenaka
Author_xml – sequence: 1
  givenname: Maino
  surname: Tahara
  fullname: Tahara, Maino
  organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 2
  givenname: Shinji
  surname: Ohno
  fullname: Ohno, Shinji
  organization: Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan
– sequence: 3
  givenname: Kouji
  surname: Sakai
  fullname: Sakai, Kouji
  organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 4
  givenname: Yuri
  surname: Ito
  fullname: Ito, Yuri
  organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan
– sequence: 5
  givenname: Hideo
  surname: Fukuhara
  fullname: Fukuhara, Hideo
  organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan
– sequence: 6
  givenname: Katsuhiro
  surname: Komase
  fullname: Komase, Katsuhiro
  organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 7
  givenname: Melinda A.
  surname: Brindley
  fullname: Brindley, Melinda A.
  organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
– sequence: 8
  givenname: Paul A.
  surname: Rota
  fullname: Rota, Paul A.
  organization: Measles, Mumps, Rubella and Herpesviruses Laboratory Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
– sequence: 9
  givenname: Richard K.
  surname: Plemper
  fullname: Plemper, Richard K.
  organization: Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
– sequence: 10
  givenname: Katsumi
  surname: Maenaka
  fullname: Maenaka, Katsumi
  organization: Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan
– sequence: 11
  givenname: Makoto
  surname: Takeda
  fullname: Takeda, Makoto
  organization: Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23283964$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1v1DAQxS3Uim4LN84o3DiQ4o_Eji9IZdXSReVDUCpuljeZZF0ldrCdLe1fX2-3RYCExGk0mt88Pb23j3ass4DQM4IPCaHV6_cXi0PMMJU5oY_QjGBZ5WVJih00w5jSvGTV9z20H8IlxqQoePEY7VFGKyZ5MUM_z1eQfYEaxuh8_tbYxtgu-2oiZK7NYjp-AB16CNmF8VPITmHQXddP0Vhjs8_eRUhzEQP0bTZ3NkQTp5hwfbeBX0OTfYQpet2bm4328WiiG-EJ2m11H-Dp_TxA306Oz-en-dmnd4v50Vlel1jGXJaypctlAwXDLaesEUJQWmBOuOZQSlEyzdqi0SAIl5IJoJxIyQVLEeBaswP0Zqs7TssBmhrsxooavRm0v1ZOG_XnxZqV6txasVJSQkUSeHkv4N2PCUJUgwk19L224KagCKOsIlzg4j9QQjmnsmIJff67rV9-HppJAN0CtXcheGhVbaKOxm1cml4RrDb1q1S_uqtfEZqeXv319KD7D_zFFl-ZbnVlPCgdBnW5NqoSiqcEktFbAU-8ZQ
CitedBy_id crossref_primary_10_1016_j_virusres_2017_04_018
crossref_primary_10_1371_journal_pone_0073374
crossref_primary_10_1128_JVI_01248_18
crossref_primary_10_1016_j_vaccine_2016_10_010
crossref_primary_10_2217_fvl_2017_0071
crossref_primary_10_3390_v8040109
crossref_primary_10_1016_j_coviro_2020_04_002
crossref_primary_10_1016_j_virol_2015_03_035
crossref_primary_10_1038_nrdp_2016_49
crossref_primary_10_3390_ijms21124435
crossref_primary_10_1016_j_virol_2014_01_027
crossref_primary_10_1016_j_ijmm_2024_151607
crossref_primary_10_3389_fmolb_2023_1302737
crossref_primary_10_3390_v9010011
crossref_primary_10_1016_j_vaccine_2015_12_006
crossref_primary_10_1093_infdis_jiv434
crossref_primary_10_2222_jsv_67_3
crossref_primary_10_1016_j_xcrm_2021_100225
crossref_primary_10_1111_febs_14991
crossref_primary_10_1128_JVI_02166_17
crossref_primary_10_3390_medicina58050680
crossref_primary_10_3390_v8080216
crossref_primary_10_1093_infdis_jiw480
crossref_primary_10_1007_s00430_016_0451_4
crossref_primary_10_1128_jvi_00758_24
crossref_primary_10_1186_s13063_022_06493_5
crossref_primary_10_1016_S0140_6736_17_31463_0
crossref_primary_10_2147_IJN_S386560
crossref_primary_10_1038_srep11648
crossref_primary_10_3390_v11111017
Cites_doi 10.1099/0022-1317-66-7-1397
10.1007/s00705-003-0159-9
10.1128/jvi.69.3.1913-1916.1995
10.1128/JVI.02691-07
10.1016/S0140-6736(03)12661-X
10.1038/nsmb.1969
10.1128/JVI.79.17.11547-11551.2005
10.1038/nature10639
10.1038/nsmb.2432
10.1128/JVI.78.1.302-313.2004
10.1371/journal.ppat.1002240
10.1128/JVI.00867-08
10.1099/vir.0.014944-0
10.1093/infdis/jir133
10.1128/JVI.74.14.6643-6647.2000
10.1074/jbc.M110.102590
10.3389/fmicb.2011.00279
10.1016/j.vaccine.2009.04.010
10.1016/0042-6822(86)90371-5
10.1128/JVI.02033-12
10.1038/35022579
10.1089/088282402760312331
10.1073/pnas.0707830104
10.1006/viro.1993.1042
10.1016/j.virusres.2011.09.023
ContentType Journal Article
Copyright Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
Copyright_xml – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
DOI 10.1128/JVI.03029-12
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts

CrossRef
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 3586
ExternalDocumentID PMC3592127
23283964
10_1128_JVI_03029_12
jvi_87_6_3583
Genre Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI083402
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
.55
.GJ
3O-
41~
6TJ
AAYJJ
ADXHL
AFFNX
AI.
C1A
CGR
CUY
CVF
D0S
ECM
EIF
MVM
NPM
OHT
VH1
X7M
Y6R
ZGI
ZXP
7X8
7T5
7U9
H94
5PM
ID FETCH-LOGICAL-c509t-959f2bbde430f623d7772240616a6e59753a3f4dae7169937e261996735140ca3
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 18:34:00 EDT 2025
Fri Jul 11 01:36:32 EDT 2025
Fri Jul 11 07:25:38 EDT 2025
Mon Jul 21 06:06:03 EDT 2025
Thu Apr 24 23:10:02 EDT 2025
Tue Jul 01 01:02:21 EDT 2025
Wed May 18 15:26:13 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c509t-959f2bbde430f623d7772240616a6e59753a3f4dae7169937e261996735140ca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://jvi.asm.org/content/jvi/87/6/3583.full.pdf
PMID 23283964
PQID 1312662983
PQPubID 23479
PageCount 4
ParticipantIDs pubmed_primary_23283964
proquest_miscellaneous_1323816704
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3592127
crossref_citationtrail_10_1128_JVI_03029_12
highwire_asm_jvi_87_6_3583
proquest_miscellaneous_1312662983
crossref_primary_10_1128_JVI_03029_12
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2013
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_10_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
Leonard VH (e_1_3_2_17_2) 2008; 118
2424173 - Virology. 1986 Jul 15;152(1):58-65
14579178 - Arch Virol. 2003 Nov;148(11):2195-206
21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240
18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40
14671112 - J Virol. 2004 Jan;78(1):302-13
23202587 - Nat Struct Mol Biol. 2013 Jan;20(1):67-72
10864679 - J Virol. 2000 Jul;74(14):6643-7
12620751 - Lancet. 2003 Mar 1;361(9359):763-73
2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409
19490984 - Vaccine. 2009 Jun 12;27(29):3838-48
23115278 - J Virol. 2013 Jan;87(1):666-75
18799577 - J Virol. 2008 Dec;82(23):11979-84
21963661 - Virus Res. 2011 Dec;162(1-2):72-9
10972291 - Nature. 2000 Aug 24;406(6798):893-7
21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7
19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9
12479395 - Viral Immunol. 2002;15(3):451-71
7685966 - Virology. 1993 Jan;192(1):351-4
18568079 - J Clin Invest. 2008 Jul;118(7):2448-58
18287234 - J Virol. 2008 May;82(9):4630-7
22347873 - Front Microbiol. 2012 Jan 13;2:279
20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90
22048310 - Nature. 2011 Dec 22;480(7378):530-3
16103210 - J Virol. 2005 Sep;79(17):11547-51
21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41
7853533 - J Virol. 1995 Mar;69(3):1913-6
References_xml – ident: e_1_3_2_14_2
  doi: 10.1099/0022-1317-66-7-1397
– ident: e_1_3_2_27_2
  doi: 10.1007/s00705-003-0159-9
– ident: e_1_3_2_24_2
  doi: 10.1128/jvi.69.3.1913-1916.1995
– ident: e_1_3_2_16_2
  doi: 10.1128/JVI.02691-07
– ident: e_1_3_2_9_2
  doi: 10.1016/S0140-6736(03)12661-X
– ident: e_1_3_2_20_2
  doi: 10.1038/nsmb.1969
– ident: e_1_3_2_6_2
  doi: 10.1128/JVI.79.17.11547-11551.2005
– ident: e_1_3_2_4_2
  doi: 10.1038/nature10639
– ident: e_1_3_2_19_2
  doi: 10.1038/nsmb.2432
– ident: e_1_3_2_18_2
  doi: 10.1128/JVI.78.1.302-313.2004
– ident: e_1_3_2_3_2
  doi: 10.1371/journal.ppat.1002240
– ident: e_1_3_2_22_2
  doi: 10.1128/JVI.00867-08
– ident: e_1_3_2_8_2
  doi: 10.1099/vir.0.014944-0
– ident: e_1_3_2_10_2
  doi: 10.1093/infdis/jir133
– ident: e_1_3_2_15_2
  doi: 10.1128/JVI.74.14.6643-6647.2000
– ident: e_1_3_2_21_2
  doi: 10.1074/jbc.M110.102590
– ident: e_1_3_2_5_2
  doi: 10.3389/fmicb.2011.00279
– ident: e_1_3_2_25_2
  doi: 10.1016/j.vaccine.2009.04.010
– ident: e_1_3_2_26_2
  doi: 10.1016/0042-6822(86)90371-5
– volume: 118
  start-page: 2448
  year: 2008
  ident: e_1_3_2_17_2
  article-title: Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed
  publication-title: J. Clin. Invest.
– ident: e_1_3_2_13_2
  doi: 10.1128/JVI.02033-12
– ident: e_1_3_2_2_2
  doi: 10.1038/35022579
– ident: e_1_3_2_7_2
  doi: 10.1089/088282402760312331
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.0707830104
– ident: e_1_3_2_23_2
  doi: 10.1006/viro.1993.1042
– ident: e_1_3_2_11_2
  doi: 10.1016/j.virusres.2011.09.023
– reference: 12479395 - Viral Immunol. 2002;15(3):451-71
– reference: 10972291 - Nature. 2000 Aug 24;406(6798):893-7
– reference: 21963661 - Virus Res. 2011 Dec;162(1-2):72-9
– reference: 18287234 - J Virol. 2008 May;82(9):4630-7
– reference: 16103210 - J Virol. 2005 Sep;79(17):11547-51
– reference: 21901103 - PLoS Pathog. 2011 Aug;7(8):e1002240
– reference: 21666216 - J Infect Dis. 2011 Jul;204 Suppl 1:S71-7
– reference: 19710253 - J Gen Virol. 2009 Dec;90(Pt 12):2982-9
– reference: 2410551 - J Gen Virol. 1985 Jul;66 ( Pt 7):1397-409
– reference: 20435897 - J Biol Chem. 2010 Jul 2;285(27):20882-90
– reference: 18003910 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19535-40
– reference: 12620751 - Lancet. 2003 Mar 1;361(9359):763-73
– reference: 22347873 - Front Microbiol. 2012 Jan 13;2:279
– reference: 18799577 - J Virol. 2008 Dec;82(23):11979-84
– reference: 7853533 - J Virol. 1995 Mar;69(3):1913-6
– reference: 14671112 - J Virol. 2004 Jan;78(1):302-13
– reference: 10864679 - J Virol. 2000 Jul;74(14):6643-7
– reference: 19490984 - Vaccine. 2009 Jun 12;27(29):3838-48
– reference: 18568079 - J Clin Invest. 2008 Jul;118(7):2448-58
– reference: 14579178 - Arch Virol. 2003 Nov;148(11):2195-206
– reference: 23115278 - J Virol. 2013 Jan;87(1):666-75
– reference: 21217702 - Nat Struct Mol Biol. 2011 Feb;18(2):135-41
– reference: 7685966 - Virology. 1993 Jan;192(1):351-4
– reference: 2424173 - Virology. 1986 Jul 15;152(1):58-65
– reference: 23202587 - Nat Struct Mol Biol. 2013 Jan;20(1):67-72
– reference: 22048310 - Nature. 2011 Dec 22;480(7378):530-3
SSID ssj0014464
Score 2.2560916
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing...
SourceID pubmedcentral
proquest
pubmed
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3583
SubjectTerms Antibodies, Neutralizing - immunology
Antibodies, Viral - immunology
Epitopes, B-Lymphocyte - immunology
Hemagglutinins, Viral - immunology
Measles virus
Measles virus - immunology
Virus-Cell Interactions
Title The Receptor-Binding Site of the Measles Virus Hemagglutinin Protein Itself Constitutes a Conserved Neutralizing Epitope
URI http://jvi.asm.org/content/87/6/3583.abstract
https://www.ncbi.nlm.nih.gov/pubmed/23283964
https://www.proquest.com/docview/1312662983
https://www.proquest.com/docview/1323816704
https://pubmed.ncbi.nlm.nih.gov/PMC3592127
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCIkXND7XDZCR4KnKyIfjJI-AOq1jG0hrp_JkuY2zZnRp1TQI9tdzZ-ero6DBS9oklmPlfjnfnf27I-QNt1UUcgyBhWNusThkFi7fWRM_CSOYDhLPQYLzySk_HLKjkT9qYrqaXbIa70-uN_JK_keqcA3kiizZf5Bs3SlcgP8gXziChOF4axmD3acW4DhbH1JDUDlLm5X_EyXzmcq75-myyGGKuZIXFzggzKj6BTM0wG9_latZoit3mm0DeVfqM9wLGYMWLHQw5Br77i1AASzWdw81Fi1S5tpB-oHEbNCGEZRm8zqeO9Xlvrtn0zS7TOsQj_xWVsaeF83Vvq7y1P1aLNN2fAJrRVQbtFp8AVCrIzPjGDWLWUzRVmvr4XLiTX9Tqp5vat2UEzSc8s3K30VCw9F5fx80l4tVHppJrlrYP_0sDobHx2LQGw3uknsuOBfaEe9_qteewEFmVY55HHdFl3DDd-2-1w2ZKrn0Jkfl5n7blgEz2CYPSznR9wZGj8gdlT0m900t0p9PyA8AE70JJopgovOEAphoCSaqwUTXwERLMFEDJtoCE5W0BhNtg4mWYHpKhge9wcdDqyzLAR-wHa2syI8SdzyOFfPsBKznOICXqA1DLrnykaktvYTFUmEmJjB_FXrpEQ-QNGJPpPeMbGXzTO0QyrC1r1joSJ-5gS-ZVAnzlB0zyZ3E6ZBu9Y7FpMxZj6VTZkL7rm4oQCJCS0Q4boe8rVsvTK6WP7TbrcQlZH4lLr-nIgwEFwi0DnldCVCApsXlM5mpeZELx3PAmnWjv7dBE5gHNuuQ50bo9VDAdwFvhMOdYA0OdQPM9L5-J0unOuO750dYiWH3Fs_dIw-ar_AF2VotC_US7ObV-JWG-S8ZXcU9
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Receptor-Binding+Site+of+the+Measles+Virus+Hemagglutinin+Protein+Itself+Constitutes+a+Conserved+Neutralizing+Epitope&rft.jtitle=Journal+of+virology&rft.au=Tahara%2C+Maino&rft.au=Ohno%2C+Shinji&rft.au=Sakai%2C+Kouji&rft.au=Ito%2C+Yuri&rft.date=2013-03-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=6&rft.spage=3583&rft.epage=3586&rft_id=info:doi/10.1128%2FJVI.03029-12&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon